Abstract
ADHD is a very common (prevalence 4–12% of US children ages 4–17 years), chronic, debilitating, and costly neurodevelopmental illness. Efficacy of stimulants is well established, and the use of treatment guidelines is encouraged, but management of childhood ADHD remains poor, especially in community-based settings. Given near-universal access to smart phones in the United States, mobile health (mHealth) holds promise for improving quality of ADHD treatment in community-based settings. Pilot study was designed to evaluate the feasibility and acceptability of MH2TM, a web-based mobile health application (app) developed to optimize early stimulant treatment for children with ADHD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
